Jul 14, 2026 03:48PM
Jun 29, 2026 07:07AM
Jun 26, 2026 08:30AM
Jun 26, 2026 07:13AM
Jun 15, 2026 06:24AM
Jun 12, 2026 11:38AM
Jun 12, 2026 11:25AM Increasing unusual call OMER TRIP SPCE PURR XP
Jun 12, 2026 09:48AM
Jun 10, 2026 07:12AM
May 13, 2026 04:19PM
May 13, 2026 04:11PM
Apr 16, 2026 08:50AM
Mar 31, 2026 04:10PM
Jan 27, 2026 09:02AM Omeros begins commercial sales of YARTEMLEA for rare blood disorder
Dec 29, 2025 05:11AM
Dec 24, 2025 10:40AM
Dec 24, 2025 10:11AM
Nov 18, 2025 11:50AM
Nov 14, 2025 06:14AM
Nov 13, 2025 04:17PM
Oct 16, 2025 08:33AM Omeros publishes study showing survival benefits of narsoplimab treatment
Oct 16, 2025 06:44AM
Oct 15, 2025 03:30PM
Oct 15, 2025 10:26AM
Sep 2, 2025 08:45AM
Aug 14, 2025 04:03PM
Jun 30, 2025 06:52AM
Jun 27, 2025 08:31AM Omeros (OMER) Submits Narsoplimab Marketing Authorization Application to the European Medicines Agency for the Treatment of TA-TMA
May 15, 2025 04:09PM
May 12, 2025 08:41AM
May 6, 2025 09:16AM
Apr 10, 2025 09:10AM
Mar 31, 2025 04:03PM
Mar 21, 2025 09:15AM
Feb 20, 2025 09:11AM Omeros (OMER) Announces Robust Results for Narsoplimab Expanded Access Program in TA-TMA
Jan 16, 2025 09:16AM
Dec 23, 2024 10:19AM
Dec 23, 2024 07:07AM
Dec 19, 2024 09:15AM
Dec 10, 2024 08:45AM
Nov 25, 2024 05:20AM
Nov 21, 2024 09:15AM Omeros (OMER) Provides Update on Progress Toward BLA Resubmission
Nov 14, 2024 06:37AM
Nov 13, 2024 04:04PM
Aug 7, 2024 04:37PM

416,461 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All